Effect of Samsca on Control of Hyponatremia and Extracellular Fluid in Cirrhotic Patients With Ascites
Status:
Unknown status
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
This study is to evaluate the efficacy of a 2-week course of tolvaptan in improving serum
sodium and the excretion of extracellular fluid in liver cirrhotic patients with ascites and
hyponatremia